Technical Evaluation and Results of the Use of TREO® Modular Aortic Endografts for the Treatment of Abdominal Aortic Aneurysms

This study is a clinical investigation as part of the post-market clinical follow-up of the TREO® abdominal aortic graft in its initial use, French, observational, multicenter, non-randomized, single-arm. Information on patient's health and the implanted device will be collected over a period of 5 consecutive years. The data collected will be analyzed on the technical success and the absence of major events (death, stroke, myocardial infarction, visceral ischemia, paraplegia, respiratory failure, renal failure, intraoperative blood loss, thromboembolic event) and possible reinterventions related to the patient's operation.

NCT Number	NCT06893952
Lead Sponsor	Vascutek Ltd.
Conditions	Aortic Aneurysm Abdominal
Enrollment	209 participants
Start Date	2025-04
Primary Completion	2025-04 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2025-03-25